BioSpace News Archive

Press Releases

ZEISS expands ophthalmic surgical workflows in Mexico with COFEPRIS approval for ARTEVO 850 and MICOR 700

May 13, 2026
·
5 min read
Press Releases

Creatv Bio Opens CLIA-Certified Laboratory to Support Oncology Drug Development

May 13, 2026
·
2 min read
Complete response letters

UniQure, Replimune shares rise as FDA’s Makary exits, but path forward unchanged

After devastating regulatory setbacks last year, shares of uniQure and Replimune rose on the news that FDA Commissioner Marty Makary is leaving. But analysts don’t expect much relief, no matter who helms the agency.

May 13, 2026
·
3 min read
·
Annalee Armstrong
Earnings

Goodbye Galapagos: chameleon company exits the island, rebrands as Lakefront

After a 12-month period that saw the Belgian biotech consider a spinout, swap out CEOs, and enter a three-way acquisition agreement involving Ouro Medicines, Galapagos now has a new moniker.

May 13, 2026
·
2 min read
·
Heather McKenzie
Press Releases

Vetter Starts Construction of a New Production Site in Germany Ceremonial groundbreaking kicks off the first construction phase

May 13, 2026
·
1 min read
Manufacturing

Bora inks $122.5M takeover of MacroGenics facility to further US expansion

MacroGenics is selling the manufacturing plant to Bora, a Taiwan-based CDMO, to raise cash to support the progress of its drug development pipeline.

May 13, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases

PharmaTher’s Sairiyo Therapeutics to Explore PD-001, Its Patented Reformulated Cepharanthine, for Hantavirus

Independent research identified cepharanthine as a potential Hantavirus entry inhibitor, supporting further evaluation of Sairiyo’s patented, orally bioavailable PD-001 cepharanthine formulation for Hantavirus

May 13, 2026
·
9 min read
Press Releases

PharmaDrug Sairiyo Therapeutics to Explore PD-001, Its Patented Reformulated Cepharanthine, for Hantavirus

Independent research identified cepharanthine as a potential Hantavirus entry inhibitor, supporting evaluation of Sairiyo’s patented, orally bioavailable PD-001 formulation of cepharanthine for Hantavirus

May 13, 2026
·
10 min read